<PAGE>   1
 
================================================================================
 
                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
 
                             ---------------------
 
                                   FORM 10-Q
 
                             ---------------------
 
(MARK ONE)
 
   [X]          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934
 
                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1997
 
                                       OR
 
   [  ]        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
                         OF THE SECURITIES ACT OF 1934
 
                         COMMISSION FILE NUMBER 0-19946
 
                             LINCARE HOLDINGS INC.
             (Exact name of registrant as specified in its charter)
 
<TABLE>
<S>                                            <C>
                   DELAWARE                                      51-0331330
       (State or other jurisdiction of                        (I.R.S. Employer
        incorporation or organization)                      Identification No.)
 
        19337 US 19 NORTH, SUITE 500,                              34624
                CLEARWATER, FL                                   (Zip Code)
   (Address of principal executive offices)
</TABLE>
 
      Registrant's telephone number, including area code:  (813) 530-7700
 
     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.  Yes X No  _
 
     Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
 
<TABLE>
<CAPTION>
                           CLASS                              OUTSTANDING AT JULY 31, 1997
                           -----                              ----------------------------
<S>                                                           <C>
Common Stock, $0.01 par value...............................       28,365,896 shares
</TABLE>
 
================================================================================
<PAGE>   2
 
                             LINCARE HOLDINGS INC.
 
                                   FORM 10-Q
                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1997
 
                                     INDEX
 
<TABLE>
<CAPTION>
                                                                      PAGE
                                                                      ----
<S>     <C>                                                           <C>
PART I.  FINANCIAL INFORMATION
Item 1  Financial Statements (unaudited)
          Condensed consolidated balance sheets.....................    3
          Condensed consolidated statements of operations...........    4
          Condensed consolidated statements of cash flows...........    5
          Notes to condensed consolidated financial statements......    6
Item 2  Management's Discussion and Analysis of Results of
          Operations and Financial Condition........................    7
 
PART II.  OTHER INFORMATION
Item 1  Legal Proceedings...........................................    9
Item 2  Changes in Securities.......................................    9
Item 3  Defaults Upon Senior Securities.............................    9
Item 4  Submission of Matters to a Vote of Security Holders.........    9
Item 5  Other Information...........................................    9
Item 6  Exhibits and Reports on Form 8-K............................    9
 
SIGNATURES..........................................................    9
</TABLE>
 
                                        2
<PAGE>   3
 
                     LINCARE HOLDINGS INC. AND SUBSIDIARIES
 
                     CONDENSED CONSOLIDATED BALANCE SHEETS
 
<TABLE>
<CAPTION>
                                                               JUNE 30,     DECEMBER 31,
                                                                 1997           1996
                                                              -----------   ------------
                                                              (UNAUDITED)
                                                                    (IN THOUSANDS)
<S>                                                           <C>           <C>
                                         ASSETS
Current assets:
  Cash and cash equivalents.................................   $  2,585       $  1,541
  Accounts and notes receivable.............................     59,437         51,090
  Income tax receivable.....................................         30            187
  Inventories...............................................      1,800          1,689
  Prepaid expenses..........................................        515            466
                                                               --------       --------
          Total current assets..............................     64,367         54,973
                                                               --------       --------
Property and equipment......................................    177,663        150,598
Less accumulated depreciation...............................     69,856         57,068
                                                               --------       --------
          Net property and equipment........................    107,807         93,530
                                                               --------       --------
Other assets:
  Goodwill..................................................    222,223        184,817
  Intangible assets.........................................     10,311          8,867
  Covenants not to compete..................................      3,724          4,478
  Other.....................................................        709            743
                                                               --------       --------
          Total other assets................................    236,967        198,905
                                                               --------       --------
               Total assets.................................   $409,141       $347,408
                                                               ========       ========
 
                          LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
  Current installments of long-term obligations.............   $  5,861       $  5,783
  Accounts payable..........................................     11,856         16,958
  Accrued expenses:
     Compensation and benefits..............................      7,200          6,895
     Other..................................................      2,322          1,704
                                                               --------       --------
          Total current liabilities.........................     27,239         31,340
Revolving credit loan.......................................     29,100          7,500
Long-term obligations, excluding current installments.......        330            734
Deferred income taxes.......................................      7,657          7,681
Minority interest...........................................        786            905
Stockholders' equity:
  Common stock..............................................        284            282
  Additional paid-in capital................................    100,216         97,335
  Retained earnings.........................................    243,529        201,631
                                                               --------       --------
          Total stockholders' equity........................    344,029        299,248
                                                               --------       --------
               Total liabilities and stockholders' equity...   $409,141       $347,408
                                                               ========       ========
</TABLE>
 
     See accompanying notes to condensed consolidated financial statements.
 
                                        3
<PAGE>   4
 
                     LINCARE HOLDINGS INC. AND SUBSIDIARIES
 
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (UNAUDITED)
 
<TABLE>
<CAPTION>
                                                  FOR THE THREE MONTHS ENDED     FOR THE SIX MONTHS ENDED
                                                  ---------------------------   ---------------------------
                                                    JUNE 30,       JUNE 30,       JUNE 30,       JUNE 30,
                                                      1997           1996           1997           1996
                                                  ------------   ------------   ------------   ------------
                                                  (IN THOUSANDS EXCEPT SHARE    (IN THOUSANDS EXCEPT SHARE
                                                      AND PER SHARE DATA)           AND PER SHARE DATA)
<S>                                               <C>            <C>            <C>            <C>
Net revenues....................................    $  108,702     $   84,970     $  209,714     $  164,742
                                                    ----------     ----------     ----------     ----------
Costs and expenses:
  Costs of goods and services...................        16,527         13,060         31,944         25,318
  Operating expenses............................        22,966         17,988         44,506         35,306
  Selling, general and administrative
     expenses...................................        21,879         17,331         42,349         33,675
  Bad debt expense..............................         1,092            841          2,097          1,639
  Depreciation expense..........................         6,620          4,980         12,935          9,765
  Amortization expense..........................         3,623          3,189          7,063          6,320
                                                    ----------     ----------     ----------     ----------
                                                        72,707         57,389        140,894        112,023
                                                    ----------     ----------     ----------     ----------
          Operating income......................        35,995         27,581         68,820         52,719
                                                    ----------     ----------     ----------     ----------
Other income (expense):
  Interest income...............................            39             55             67             87
  Interest expense..............................          (475)           (79)          (701)          (164)
  Net loss on disposal of property and
     equipment..................................           (40)            (5)           (59)           (11)
                                                    ----------     ----------     ----------     ----------
                                                          (476)           (29)          (693)           (88)
                                                    ----------     ----------     ----------     ----------
          Income before income taxes............        35,519         27,552         68,127         52,631
Income taxes....................................        13,676         10,607         26,229         20,262
                                                    ----------     ----------     ----------     ----------
          Net income............................    $   21,843     $   16,945     $   41,898     $   32,369
                                                    ==========     ==========     ==========     ==========
Income per common share.........................    $     0.75     $     0.59     $     1.44     $     1.13
                                                    ==========     ==========     ==========     ==========
Weighted average number of common shares and
  common share equivalents outstanding..........    29,195,637     28,867,381     29,180,737     28,742,439
                                                    ==========     ==========     ==========     ==========
</TABLE>
 
     See accompanying notes to condensed consolidated financial statements.
 
                                        4
<PAGE>   5
 
                     LINCARE HOLDINGS INC. AND SUBSIDIARIES
 
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                  (UNAUDITED)
 
<TABLE>
<CAPTION>
                                                              FOR THE SIX MONTHS ENDED
                                                              ------------------------
                                                              JUNE 30,       JUNE 30,
                                                                1997           1996
                                                              ---------      ---------
                                                                   (IN THOUSANDS)
<S>                                                           <C>            <C>
Cash from operations........................................   $ 52,602       $ 47,724
Investing activities:
  Proceeds from sale of property and equipment..............        102            185
  Capital expenditures......................................    (24,901)       (15,722)
  Decrease (increase) in other assets.......................         35           (396)
  Business acquisitions, net of cash acquired...............    (45,094)       (36,226)
                                                               --------       --------
                                                                (69,858)       (52,159)
                                                               --------       --------
Financing activities:
  Proceeds from revolving line of credit....................     53,000         15,000
  Payment on revolving line of credit.......................    (32,900)        (9,000)
  Payment of long-term obligations..........................     (3,049)        (3,319)
  Decrease in minority interest.............................       (244)          (226)
  Proceeds from issuance of common stock....................      1,493          2,299
                                                               --------       --------
                                                                 18,300          4,754
                                                               --------       --------
Increase in cash............................................      1,044            319
Cash and cash equivalents, beginning of period..............      1,541          1,009
                                                               --------       --------
Cash and cash equivalents, end of period....................   $  2,585       $  1,328
                                                               ========       ========
</TABLE>
 
     See accompanying notes to condensed consolidated financial statements.
 
                                        5
<PAGE>   6
 
                             LINCARE HOLDINGS INC.
 
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                  (UNAUDITED)
 
NOTE 1 -- BASIS OF PRESENTATION
 
     The accompanying condensed consolidated balance sheet as of June 30, 1997
and condensed statements of operations and cash flows for the six months ended
June 30, 1997 and 1996 are unaudited. In the opinion of management, all
adjustments, consisting of normal recurring accruals, necessary for a fair
presentation of the results of operations for the interim periods presented have
been reflected herein. The results of operations for interim periods are not
necessarily indicative of the results to be expected for the entire year. The
accompanying condensed consolidated balance sheet as of December 31, 1996 is
derived from the Lincare Holdings Inc. (the "Company") audited balance sheet as
of that date.
 
NOTE 2 -- BUSINESS COMBINATIONS
 
     During the six months ended June 30, 1997 the Company acquired, in
unrelated acquisitions, the stock of three companies and certain assets of eight
companies. Each acquisition was accounted for as a purchase. The results of the
acquired companies are included in the accompanying consolidated statements of
operations since the respective date of acquisition.
 
     The aggregate cost of these acquisitions was as follows:
 
<TABLE>
<CAPTION>
                                                              (IN THOUSANDS)
                                                              --------------
<S>                                                           <C>
Cash........................................................     $45,094
Deferred acquisition obligations............................       3,850
Assumption of liabilities...................................         144
Other.......................................................         199
                                                                 -------
                                                                 $49,287
                                                                 =======
</TABLE>
 
     The aggregate purchase price was allocated as follows:
 
<TABLE>
<S>                                                           <C>
Current assets..............................................     $ 2,232
Property and equipment......................................       2,472
Intangible assets...........................................       5,011
Goodwill....................................................      39,572
                                                                 -------
                                                                 $49,287
                                                                 =======
</TABLE>
 
     Unaudited pro forma supplemental information on the results of operations
for the six months ended June 30, 1997 and June 30, 1996 are provided below and
reflect the acquisitions as if they had been combined at the beginning of each
respective period.
 
<TABLE>
<CAPTION>
                                                              FOR THE SIX MONTHS ENDED
                                                                      JUNE 30,
                                                              ------------------------
                                                                1997           1996
                                                              ---------      ---------
                                                               (IN THOUSANDS, EXCEPT
                                                                  PER SHARE DATA)
<S>                                                           <C>            <C>
Net revenues................................................   $219,010       $181,848
                                                               ========       ========
Net income..................................................   $ 43,240       $ 35,284
                                                               ========       ========
Income per common share.....................................   $   1.48       $   1.23
                                                               ========       ========
</TABLE>
 
     The unaudited pro forma financial information is not necessarily indicative
of either the results of operations that would have occurred had the
transactions been effected at the beginning of the respective preceding periods
or of future results of operations of the combined companies.
 
                                        6
<PAGE>   7
 
                             LINCARE HOLDINGS INC.
 
                    MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
OPERATING RESULTS
 
     The following table sets forth for the periods indicated a summary of the
Company's net revenues by source:
 
<TABLE>
<CAPTION>
                                                FOR THE THREE MONTHS    FOR THE SIX MONTHS
                                                   ENDED JUNE 30,         ENDED JUNE 30,
                                                ---------------------   -------------------
                                                  1997        1996        1997       1996
                                                ---------   ---------   --------   --------
                                                   (IN THOUSANDS)         (IN THOUSANDS)
<S>                                             <C>         <C>         <C>        <C>
Oxygen and other respiratory therapy..........   $ 96,772    $ 77,861   $188,222   $151,055
Home medical equipment and other..............     11,930       7,109     21,492     13,687
                                                 --------    --------   --------   --------
          Total...............................   $108,702    $ 84,970   $209,714   $164,742
                                                 ========    ========   ========   ========
</TABLE>
 
     Net revenues for the three months ended June 30, 1997 increased by
$23,732,000 (or 27.9%) compared with the three months ended June 30, 1996, and
for the six months ended June 30, 1997 increased $44,972,000 (or 27.3%) compared
with the six months ended June 30, 1996. Approximately $12,418,000 of the net
revenue increase for the three months ended June 30, 1997 and $23,686,000 for
the six months ended June 30, 1997 is attributable to acquisitions, while
$11,314,000 for the three months ended June 30, 1997 and $21,286,000 for the six
months ended June 30, 1997 reflects internal growth.
 
     On August 5, 1997, the Balanced Budget Act of 1997 ("BBA") was signed into
law. The legislation, among other things, reduces Medicare expenditures by $115
billion over five years. The BBA reduces Medicare payment amounts for oxygen and
oxygen equipment furnished after January 1, 1998 to 75 percent of the fee
schedule amounts in effect during 1997. Payment amounts for oxygen and oxygen
equipment furnished after January 1, 1999 and each subsequent year are reduced
to 70 percent of the fee schedule amounts in effect during 1997. During the
six-month period ended June 30, 1997, Lincare derived approximately 46% of its
net revenues from Medicare-funded home oxygen services.
 
     The BBA freezes the Consumer Price Index (U.S. urban average) update for
covered items of durable medical equipment for each of the years 1998 through
2002 while limiting fees for parenteral and enteral nutrients, supplies and
equipment to 1995 reasonable charge levels over the same period. The BBA reduces
payment amounts for covered drugs and biologicals to 95 percent of the average
wholesale price of such covered items for each of the years 1998 through 2002.
 
     The BBA authorizes the Department of Health and Human Services to conduct
up to five competitive bidding demonstration projects for the acquisition of
durable medical equipment and requires that one such project be established for
oxygen and oxygen equipment. Each demonstration project is to be operated over a
three-year period and is to be conducted in not more than three competitive
acquisition areas. The BBA also includes provisions designated to reduce health
care fraud and abuse including a surety bond requirement for durable medical
equipment providers.
 
     On August 10, 1993, Congress passed the Omnibus Reconciliation Act of 1993
("OBRA 93"). The OBRA 93 legislation provided for a consumer price index update,
effective January 1, 1997, of approximately 2.8% on Medicare products and
services. No additional impact from OBRA 93 is expected for 1997.
 
     Cost of goods and services as a percentage of net revenues was 15.2% for
the three months ended June 30, 1997 compared with 15.4% for the three months
ended June 30, 1996. Cost of goods and services as a percentage of net revenues
for the six months ended June 30, 1997 was 15.2% compared with 15.4% for the six
months ended June 30, 1996.
 
                                        7
<PAGE>   8
 
     Operating expenses as a percentage of net revenues was 21.1% for the three
months ended June 30, 1997 compared with 21.2% for the three months ended June
30, 1996. Operating expenses as a percentage of net revenues for the six months
ended June 30, 1997 was 21.2% compared with 21.4% for the six months ended June
30, 1996. This improvement was primarily due to the Company's successful
integration of acquired businesses into its existing locations. The company has
been able to maintain a cost structure that, with increases in net revenue,
allows the Company to spread its overhead over the larger base of revenue,
resulting in improvements in operating income.
 
     Selling, general and administrative expenses as a percentage of net
revenues decreased to 20.1% for the three months ended June 30, 1997 compared
with 20.4% for the three months ended June 30, 1996, and 20.2% for the six
months ended June 30, 1997 compared with 20.4% for the six months ended June 30,
1996. The improvement is attributable to the Company's continued ability to
leverage its infrastructure, with selling, general and administrative expenses
increasing by 26.2% and 25.8% while revenues grew by 27.9% and 27.3%,
respectively, for the three and six months ended June 30, 1997.
 
     Amortization expense for the three months ended June 30, 1997 increased to
$3,623,000 compared with $3,189,000 for the three month period ending June 30,
1996. Amortization expense increased to $7,063,000 for the six months ended June
30, 1997 compared with $6,320,000 for the six months ended June 30, 1996. This
increase is attributable to the amortization of intangible assets acquired
during 1996 and the first six months of 1997.
 
     Operating income for the three and six months ended June 30, 1997 increased
to $35,995,000 and $68,820,000, respectively, compared with $27,581,000 and
$52,719,000 for the three and six months ended June 30, 1996. The increases in
operating income are attributable to the continued internal and acquisition
revenue growth and efforts to control costs.
 
LIQUIDITY AND CAPITAL RESOURCES
 
     Net cash provided from operating activities was $52,602,000 for the six
months ended June 30, 1997 compared with $47,724,000 for the six months ended
June 30, 1996.
 
     Net cash used in investing and financing activities was $51,558,000 for the
six months ended June 30, 1997 compared with $47,405,000 for the six months
ended June 30, 1996. Activity in the six months ended June 30, 1997 included the
Company's investment of $45,094,000 in business acquisitions, investment in
capital equipment of $24,901,000, the borrowing of $53,000,000 from its
revolving line of credit, payments of $32,900,000 on the revolving line of
credit and payments of $3,049,000 related to deferred acquisition obligations.
The company believes that internally generated funds, together with funds that
may be borrowed under such credit facility, will be sufficient to meet the
Company's anticipated capital requirements over the foreseeable future.
 
FORWARD LOOKING STATEMENTS
 
     Statements contained in this Form 10-Q that are not based on historical
facts are forward looking statements, subject to uncertainties and risks,
including, but not limited to, the constantly changing healthcare environment,
potential reductions in reimbursement by government and third party payors for
the Company's products and services, the demand for Company's products and
services, economic and competitive conditions, the availability of appropriate
acquisition candidates and the successful completion of acquisitions, access to
borrowed and/or equity capital on favorable terms, and other risks detailed in
the Company's Securities and Exchange Commission filings.
 
                                        8
<PAGE>   9
 
PART II.  OTHER INFORMATION
 
Items 1-5  Not applicable.
 
Item  6    Exhibits and Reports on Form 8-K
 
     (a) Exhibits:
 
<TABLE>
<CAPTION>
                                                                             SEQUENTIALLY
EXHIBIT                                                                        NUMBERED
NUMBER                                   EXHIBIT                                 PAGE
-------                                  -------                             ------------
<C>       <C>  <S>                                                           <C>
  27.0    --   Financial Data Schedule (for SEC Use Only)..................
</TABLE>
 
     (b) The Company did not file a Current Report on Form 8-K during the three
months ended June 30, 1997.
 
                                   SIGNATURES
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
 
                                                  Lincare Holdings Inc.
 
                                          --------------------------------------
                                                        Registrant
 
                                                   /s/ PAUL G. GABOS
                                          --------------------------------------
                                                      Paul G. Gabos
                                            Secretary, Chief Financial Officer
                                             and Principal Accounting Officer
 
August 14, 1997
 
                                        9